Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens K Habermann

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Proteomics|July 6, 2016
Possibilities and limitations of 2DE-based analyses for identifying low-abundant tumor markers in human serum and plasmaSarah Strohkamp, Timo Gemoll, Jens K Habermann
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|September 5, 2015
Applying Genomics and Proteomics in Translational Surgical Oncology ResearchTimo Gemoll, Rüdiger Meyer, Jens K Habermann
Molecular Medicine Reports|August 30, 2011
MALDI mass spectrometry imaging in oncology (Review)Timo Gemoll, Uwe J Roblick, Jens K Habermann
Cytotechnology|January 15, 2010
Comparison of five commercial extraction kits for subsequent membrane protein profilingStefanie Bünger, Uwe J Roblick, Jens K Habermann
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 18, 2015
Genetic Instability and Disease PrognosticationTimo Gemoll, Gert Auer, Thomas Ried, et al.
Oncotarget|November 12, 2015
MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancerTimo Gemoll, Sarah Strohkamp, Katharina Schillo, et al.
Advances in Experimental Medicine and Biology|December 14, 2006
From genome to proteome in tumor profiling: molecular events in colorectal cancer genesisJens K Habermann, Uwe J Roblick, Madhvi Upender, et al.
International Journal of Colorectal Disease|October 22, 2016
Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysisRüdiger Meyer, Sandra Freitag-Wolf, Silke Blindow, et al.
Studies in Health Technology and Informatics|September 1, 2016
Metadata Repository for Improved Data Sharing and Reuse Based on HL7 FHIRHannes Ulrich, Ann-Kristin Kock, Petra Duhm-Harbeck, et al.
International Journal of Colorectal Disease|June 10, 2015
Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overviewTilman Laubert, Sandra Freitag-Wolf, Michael Linnebacher, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Proteomics|July 6, 2016
Possibilities and limitations of 2DE-based analyses for identifying low-abundant tumor markers in human serum and plasmaSarah Strohkamp, Timo Gemoll, Jens K Habermann
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|September 5, 2015
Applying Genomics and Proteomics in Translational Surgical Oncology ResearchTimo Gemoll, Rüdiger Meyer, Jens K Habermann
Molecular Medicine Reports|August 30, 2011
MALDI mass spectrometry imaging in oncology (Review)Timo Gemoll, Uwe J Roblick, Jens K Habermann
Cytotechnology|January 15, 2010
Comparison of five commercial extraction kits for subsequent membrane protein profilingStefanie Bünger, Uwe J Roblick, Jens K Habermann
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 18, 2015
Genetic Instability and Disease PrognosticationTimo Gemoll, Gert Auer, Thomas Ried, et al.
Oncotarget|November 12, 2015
MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancerTimo Gemoll, Sarah Strohkamp, Katharina Schillo, et al.
Advances in Experimental Medicine and Biology|December 14, 2006
From genome to proteome in tumor profiling: molecular events in colorectal cancer genesisJens K Habermann, Uwe J Roblick, Madhvi Upender, et al.
International Journal of Colorectal Disease|October 22, 2016
Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysisRüdiger Meyer, Sandra Freitag-Wolf, Silke Blindow, et al.
Studies in Health Technology and Informatics|September 1, 2016
Metadata Repository for Improved Data Sharing and Reuse Based on HL7 FHIRHannes Ulrich, Ann-Kristin Kock, Petra Duhm-Harbeck, et al.
International Journal of Colorectal Disease|June 10, 2015
Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overviewTilman Laubert, Sandra Freitag-Wolf, Michael Linnebacher, et al.
Pageof 8